09:46 AM EST - Cardiome Pharma Corp. : Reported financial results for its first quarter ended March 31, 2016. Cardiome recorded a net loss of $1.2 million (loss per share of $0.06) for the three months ended March 31, 2016, compared to a net loss of $3.9 million (loss per share of $0.23) for the three months ended March 31, 2015. Revenue for the three months ended March 31, 2016 was $7.1 million compared to revenue of $5.5 million for the three months ended March 31, 2015. All figures in U.S. dollars. Cardiome Pharma Corp.
shares T.COM are trading unchanged at $6.25.
